In addition to identifying three tainted syrups produced in India, including the notorious Coldrif cough syrup, the World Health Organization (WHO) has asked authorities elsewhere to notify the organization if any of these items are found in their own nations.

This comes weeks after the ingestion of tainted cough syrup was implicated in the deaths of multiple youngsters in Madhya Pradesh.

Coldrif is one of the three tainted syrups that the WHO has identified; it recently caused a great deal of outrage after the children died.

Certain batches of Coldrif from Sresan Pharmaceuticals, Respifresh TR from Rednex Pharmaceuticals, and ReLife from Shape Pharma have been identified by the world health body as the impacted medications.

WHO issued a warning that serious and maybe fatal infections could result from the identified syrups.

When it was discovered that the Tamil Nadu-made Coldrif syrup was seriously tainted with the hazardous chemical diethylene glycol (DEG), it caused a great deal of concern.

Tests showed that DEG concentrations were above 48%, which is a concerning amount that is significantly higher than the allowable limit of 0.1%.

Following this, G. Ranganathan, the proprietor of Sresan Pharmaceuticals, was taken into custody and the company’s manufacturing license was withdrawn.

In order to find any possible breaches in quality control, the authorities also mandated a thorough examination of other pharmaceutical manufacturing facilities located throughout the southern state.

The Central government advised all states and union territories to use great caution when prescribing cough syrups for children in response to the deaths of children in Madhya Pradesh.

According to the recommendation, children under the age of two should not be prescribed or given such medications, and people under the age of five should generally avoid taking them.

In order to avoid such tragedies, health officials have emphasized that the episode underscores the urgent need for tighter regulatory monitoring of pharmaceutical manufacture in the nation.